Clinical Diabetes and Epidemiology, Baker Heart and Diabetes Institute, Melbourne, Australia.
Department of Surgery, Division of Transplantation, Emory University School of Medicine, Atlanta, GA, USA.
Int J Epidemiol. 2021 Aug 30;50(4):1362-1372. doi: 10.1093/ije/dyaa270.
Excess mortality in people with vs without type 2 diabetes (T2DM) has fallen, but it is unclear whether men/women at all ages have benefited and which causes of death have driven these trends.
All-cause and cause-specific mortality rates and excess mortality [by mortality rate ratios (MRRs) relative to the non-diabetic general population] were examined in 1 268 018 Australians with T2DM registered on the National Diabetes Services Scheme (2002-2014).
Age-standardized mortality decreased in men (-2.2%/year; Ptrend < 0.001) and women with T2DM (-1.3%/year; Ptrend < 0.001) throughout 2002-14, which translated to declines in the MRRs (from 1.51 to 1.45 in men; 1.59 to 1.46 in women; Ptrend < 0.05 for both). Declining mortality rates in T2DM were observed in men aged 40+ years and women aged 60+ years (Ptrends <0.001), but not at younger ages. However, the only age group in which excess mortality declined relative to those without diabetes was 80+ years (Ptrends < 0.05); driven by reductions in excess cancer-related deaths in men and cardiovascular disease (CVD) in women. Among age groups <80 years, CVD and cancer MRRs remained similar or increased over time, despite falls in both CVD and cancer mortality rates. MRRs for non-CVD/non-cancer-related deaths increased in 60-79 year-olds, but were otherwise unchanged.
Declining excess mortality attributable to T2DM from 2002-14 was driven entirely by reductions in those aged 80+ years. Declines in total mortality among those with T2DM were apparent in more age groups, but often to a lesser extent than in the general population, thereby serving to increase the excess risk associated with T2DM.
患有 2 型糖尿病(T2DM)的人群与无糖尿病人群相比,死亡率已经下降,但尚不清楚所有年龄段的男性/女性是否都受益,以及哪些死因导致了这些趋势。
在参与国家糖尿病服务计划(2002-2014 年)的 1268018 名 T2DM 患者中,检查了全因和特定死因死亡率以及超额死亡率[通过与非糖尿病普通人群的死亡率比(MRR)表示]。
2002-14 年期间,男性(-2.2%/年;Ptrend <0.001)和女性(-1.3%/年;Ptrend <0.001)的年龄标准化死亡率均下降,这导致 MRR 下降(男性从 1.51 降至 1.45;女性从 1.59 降至 1.46;两者均 Ptrend <0.05)。在 40 岁以上的男性和 60 岁以上的女性中观察到 T2DM 死亡率下降(Ptrends <0.001),但在年轻年龄段则不然。然而,与无糖尿病患者相比,超额死亡率下降的唯一年龄组是 80 岁以上组(Ptrends <0.05);这归因于男性癌症相关死亡和女性心血管疾病(CVD)死亡的减少。在<80 岁的年龄组中,尽管 CVD 和癌症死亡率下降,但 CVD 和癌症的 MRR 仍保持相似或增加。60-79 岁年龄组的非 CVD/非癌症相关死亡的 MRR 增加,但其他方面保持不变。
2002-14 年 T2DM 归因于超额死亡率的下降完全是由 80 岁以上人群的减少所致。在 T2DM 患者中,总死亡率的下降在更多的年龄组中表现明显,但往往低于普通人群,从而增加了与 T2DM 相关的超额风险。